Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) was $23.03 for the day, up 4.54% from the previous closing price of $22.03. In other words, the price has increased by $4.54 from its previous closing price. On the day, 0.51 million shares were traded. KNSA stock price reached its highest trading level at $23.17 during the session, while it also had its lowest trading level at $22.17.
Ratios:
Our analysis of KNSA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 149.80. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 13, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.
BofA Securities reiterated its Buy rating for the stock on June 29, 2020, while the target price for the stock was revised from $25 to $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 06 ’24 when Patel Sanj K bought 89,561 shares for $23.00 per share.
Tessari Eben sold 17,000 shares of KNSA for $456,790 on Oct 15 ’24. The CHIEF OPERATING OFFICER now owns 109,975 shares after completing the transaction at $26.87 per share. On Oct 15 ’24, another insider, Tessari Eben, who serves as the Officer of the company, bought 17,000 shares for $26.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 1591292288 and an Enterprise Value of 1449617024. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.33 while its Price-to-Book (P/B) ratio in mrq is 3.80. Its current Enterprise Value per Revenue stands at 3.774 whereas that against EBITDA is -59.408.
Stock Price History:
Over the past 52 weeks, KNSA has reached a high of $28.15, while it has fallen to a 52-week low of $14.12. The 50-Day Moving Average of the stock is -8.27%, while the 200-Day Moving Average is calculated to be 6.54%.
Shares Statistics:
KNSA traded an average of 360.13K shares per day over the past three months and 401140 shares per day over the past ten days. A total of 72.20M shares are outstanding, with a floating share count of 39.66M. Insiders hold about 45.07% of the company’s shares, while institutions hold 50.46% stake in the company. Shares short for KNSA as of 1728950400 were 4006718 with a Short Ratio of 11.13, compared to 1726185600 on 4636433. Therefore, it implies a Short% of Shares Outstanding of 4006718 and a Short% of Float of 12.42.
